<?xml version="1.0" encoding="UTF-8"?>
<p id="par0025">In February the CEPI started studying the range of candidates for a COVID-19 vaccine by used sources of all types, including vaccine candidate products under evaluation and included in the continuously updated WHO list of authorised products. It also studies the information arising from announcements, direct communications with vaccine developers, clinical trial and financial databases, press releases and publically available literature.</p>
